Advocacy is the act of supporting a cause or idea. It involves speaking out on issues that you care about and offering ways to improve upon them.
Anyone can become an advocate! The IMF's multiple myeloma cancer advocacy group helps guide individuals to advocate for critical health issues that affect the multiple myeloma community. Whether you are a patient, caregiver, doctor, nurse, or friend, your opinion does matter. The only way we can make a difference is to TAKE ACTION!
Support legislation aimed to provide benefits for BWN vets.
On January 17, 2019, The IMF joined with over 50 patient advocacy groups in an ad campaign to ensure Medicare Part D patients continue to have access to drugs in the Six Protected Classes, which include many drugs used to treat cancer.
H.R. 913 aims to improve access to clinical trials for Medicaid enrollees by requiring states to provide coverage of routine patient costs in connection with participation in qualifying clinical trials.
Our Advocacy Team conveys to the Administration the perspectives and experiences of myeloma patients affected by high out-of-pocket drug costs.
The IMF tracks state health policy issues that will affect the multiple myeloma community. Since 2010 we have been working to pass Oral Anticancer Treatment Access Legislation. As of April 2017, 43 States and Washington, D.C. have passed this type of law. You can learn more about our coalition at the State Patients Equal Access Coalition webpage.
Insured cancer patients are fighting for their lives, but being hit every single month with skyhigh out of pocket costs to get their life-saving cancer treatments, just because it comes in pill form. Move H206 for a vote this special session
Help SB 1034 pass the Idaho State Senate by contacting your senator today!
Please urge Senator Berger to move the Cancer Treatment Fairness Act (HB206) forward in January so that the out-of-pocket costs for oral and infusion chemotherapy are treated the same.
Subscribe to receive advocacy alerts and campaign notices.